window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 21, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

oncology research

  • Artificial Intelligence,Biotech,Drug discovery,Oncology,Partnerships & Funding,Research & Development,Technology and platforms

    Evogene partners QUT on AI drug discovery for lung cancer resistance

    Evogene Ltd has partnered with Queensland University of Technology to [...]

    February 19, 2026
  • Clinical studies,Drug Development,Oncology,Precision medicine,Research & Development

    Nine-gene signature linked to lapatinib resistance in HER2-positive breast cancer

    Researchers at City St George’s, University of London have identified [...]

    January 29, 2026
  • Artificial Intelligence,Clinical Development,Drug Development,Research & Development

    Soley Therapeutics study suggests live cell stress signals could reveal drug mechanisms

    Soley Therapeutics has published a peer-reviewed study describing a method [...]

    January 22, 2026
  • Uncategorised

    MaaT Pharma randomizes first patient in IMMUNOLIFE Phase 2 NSCLC microbiome study

    MaaT Pharma has randomized the first patient in the IMMUNOLIFE [...]

    January 21, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Oncology,Research & Development

    Breast cancer tops list of most-studied diseases for fifth consecutive year, Phesi analysis finds

    Breast cancer remained the world’s most studied disease for the [...]

    January 9, 2026
  • Clinical Trials,Oncology,Research & Development

    Heidelberg Pharma sees complete remissions in HDP-101 multiple myeloma trial

    Heidelberg Pharma has reported further clinical activity from its Phase [...]

    November 6, 2025
  • Artificial Intelligence,Clinical studies,Digital Health,Global health,Oncology,Partnerships & Funding,Women's Health

    SpotitEarly and Hackensack Meridian Health partner to advance early detection with trained dogs

    SpotitEarly, a US-based early cancer detection startup, has announced a [...]

    October 1, 2025
  • Clinical Trials,Oncology,Patient Centricity,Technology and platforms

    START launches Hope Hub to improve access to early-phase cancer trials

    START unveils the Hope Hub, a digital platform connecting patients, [...]

    July 2, 2025
  • Clinical Trials,Drug Development,Regulatory Affairs

    Why patient-centric trial design is the future of oncology: Q&A with One2Treat’s chief medical officer Pascal Piedbois

    As oncology research continues to evolve, the focus is increasingly [...]

    May 30, 2025
  • Clinical Trials

    Heidelberg Pharma advances lead candidates and extends cash runway

    April 28, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome
    Categories: Central Nervous System, Clinical Development, Drug Delivery & Formulation, Drug Development, Neurosciences, Patient Centricity
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Obesity, Pharmaceuticals and therapeutics, Research & Development
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top